NCT04756661View on ClinicalTrials.gov

Uterotonics for Severe Preeclampsia

NACompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

February 10, 2021

Conditions
Preeclampsia Severe
Interventions
DRUG

Carbetocin

100 mcg of Carbetocin intravenous injection

DRUG

Oxytocin

10 IU oxytocin IV drip

DRUG

Misoprostol

400 mcg rectal

Trial Locations (1)

Unknown

Assiut Faculty of Medicine, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04756661 - Uterotonics for Severe Preeclampsia | Biotech Hunter | Biotech Hunter